ArticleClinical and translational science2020

Predicting Cost-Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States.

Ching-Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.